Literature DB >> 28820879

A kinetic view of GPCR allostery and biased agonism.

J Robert Lane1, Lauren T May1, Robert G Parton2, Patrick M Sexton1, Arthur Christopoulos1.   

Abstract

G-protein-coupled receptors (GPCRs) are one of the most tractable classes of drug targets. These dynamic proteins can adopt multiple active states that are linked to distinct functional outcomes. Such states can be differentially stabilized by ligands interacting with the endogenous agonist-binding orthosteric site and/or by ligands acting via spatially distinct allosteric sites, leading to the phenomena of 'biased agonism' or 'biased modulation'. These paradigms are having a major impact on modern drug discovery, but it is becoming increasingly apparent that 'kinetic context', at the level of both ligand-receptor and receptor-signal pathway kinetics, can have a profound impact on the observation and quantification of these phenomena. The concept of kinetic context thus represents an important new consideration that should be routinely incorporated into contemporary chemical biology and drug discovery studies of GPCR bias and allostery.

Mesh:

Substances:

Year:  2017        PMID: 28820879     DOI: 10.1038/nchembio.2431

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  94 in total

Review 1.  Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

Authors:  Peter Keov; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

2.  Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists.

Authors:  Julien Louvel; Dong Guo; Marjolein Soethoudt; Tamara A M Mocking; Eelke B Lenselink; Thea Mulder-Krieger; Laura H Heitman; Adriaan P IJzerman
Journal:  Eur J Med Chem       Date:  2015-07-15       Impact factor: 6.514

3.  Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

Authors:  Eneko Urizar; Lucia Montanelli; Tiffany Loy; Marco Bonomi; Stéphane Swillens; Céline Gales; Michel Bouvier; Guillaume Smits; Gilbert Vassart; Sabine Costagliola
Journal:  EMBO J       Date:  2005-05-12       Impact factor: 11.598

4.  Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor.

Authors:  P Ghanouni; Z Gryczynski; J J Steenhuis; T W Lee; D L Farrens; J R Lakowicz; B K Kobilka
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

Review 5.  Endosomes: a legitimate platform for the signaling train.

Authors:  Jane E Murphy; Benjamin E Padilla; Burcu Hasdemir; Graeme S Cottrell; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

6.  Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

Authors:  F J Ehlert
Journal:  Mol Pharmacol       Date:  1988-02       Impact factor: 4.436

7.  FRET-based measurement of GPCR conformational changes.

Authors:  Sébastien Granier; Samuel Kim; Juan José Fung; Michael P Bokoch; Charles Parnot
Journal:  Methods Mol Biol       Date:  2009

Review 8.  Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.

Authors:  Katie Leach; Patrick M Sexton; Arthur Christopoulos
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

9.  Structural features for functional selectivity at serotonin receptors.

Authors:  Daniel Wacker; Chong Wang; Vsevolod Katritch; Gye Won Han; Xi-Ping Huang; Eyal Vardy; John D McCorvy; Yi Jiang; Meihua Chu; Fai Yiu Siu; Wei Liu; H Eric Xu; Vadim Cherezov; Bryan L Roth; Raymond C Stevens
Journal:  Science       Date:  2013-03-21       Impact factor: 47.728

10.  The role of interfacial lipids in stabilizing membrane protein oligomers.

Authors:  Kallol Gupta; Joseph A C Donlan; Jonathan T S Hopper; Povilas Uzdavinys; Michael Landreh; Weston B Struwe; David Drew; Andrew J Baldwin; Phillip J Stansfeld; Carol V Robinson
Journal:  Nature       Date:  2017-01-11       Impact factor: 49.962

View more
  43 in total

1.  Fluorescent bioorthogonal labeling of class B GPCRs in live cells.

Authors:  Srikanth Kumar Gangam; Qing Lin
Journal:  Methods Enzymol       Date:  2020-06-15       Impact factor: 1.600

2.  Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor.

Authors:  Vanessa A Gutzeit; Jordana Thibado; Daniel Starer Stor; Zhou Zhou; Scott C Blanchard; Olaf S Andersen; Joshua Levitz
Journal:  Elife       Date:  2019-06-07       Impact factor: 8.140

Review 3.  A Biased View of μ-Opioid Receptors?

Authors:  Alexandra E Conibear; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

4.  Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes.

Authors:  Carrie German; Minu Pilvankar; Andrzej Przekwas
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-08-08       Impact factor: 2.745

5.  Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.

Authors:  Kathy Sengmany; Shane D Hellyer; Sabine Albold; Taide Wang; P Jeffrey Conn; Lauren T May; Arthur Christopoulos; Katie Leach; Karen J Gregory
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

6.  Increasing kinase domain proximity promotes MST2 autophosphorylation during Hippo signaling.

Authors:  Thao Tran; Jaba Mitra; Taekjip Ha; Jennifer M Kavran
Journal:  J Biol Chem       Date:  2020-09-29       Impact factor: 5.157

Review 7.  New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.

Authors:  Elizabeth A Vecchio; Jo-Anne Baltos; Anh T N Nguyen; Arthur Christopoulos; Paul J White; Lauren T May
Journal:  Br J Pharmacol       Date:  2018-06-21       Impact factor: 8.739

Review 8.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

9.  Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modelling.

Authors:  Xiao Zhu; David B Finlay; Michelle Glass; Stephen B Duffull
Journal:  Br J Pharmacol       Date:  2020-05-15       Impact factor: 8.739

Review 10.  A cellular perspective of bias at G protein-coupled receptors.

Authors:  Thomas J Fernandez; Monica De Maria; Braden T Lobingier
Journal:  Protein Sci       Date:  2020-04-27       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.